{"id":{"repo_id":"etsu","oai_identifier":"oai:dc.etsu.edu:etd-5023"},"canonical_url":"https://search.ndltd.org/etd/etsu/oai:dc.etsu.edu:etd-5023","repository":{"repo_id":"etsu","name":"East Tennessee State University","base_url":"https://dc.etsu.edu/do/oai/"},"display":{"title":"Effect of Prebiotic, Probiotic, and Enzyme Supplementation on Gut Fermentation, Markers of Inflammation and Immune Response in Individuals with GI Symptoms","abstract":"Current practices support the use of probiotic and prebiotic supplementation to improve chronic gastrointestinal distress (GID). The aim of this study was to determine the tolerance and benefits of GlutenShield (GS), a prebiotic, probiotic, and enzyme supplement, on adults with GID. Subjects (n=20) took either GS or the placebo for 30 days and completed a pre-treatment FFQ as well as a pre- and post-treatment GID questionnaire, blood draw, and stool sample. Participants consumed more total and saturated fat, and less fiber and whole grains compared to the recommended intake. A significant reduction in IgG2 was observed in the GS group (p=0.008) as well as a significant reduction in self-reported bloating (p=0.038) with no change observed to cytokines or SCFAs (p>0.05). GS was well tolerated and perceived to be beneficial; however, further research is needed to identify the specific population of GID patients who could most benefit from GS supplementation.","abstract_html":"Current practices support the use of probiotic and prebiotic supplementation to improve chronic gastrointestinal distress (GID). The aim of this study was to determine the tolerance and benefits of GlutenShield (GS), a prebiotic, probiotic, and enzyme supplement, on adults with GID. Subjects (n=20) took either GS or the placebo for 30 days and completed a pre-treatment FFQ as well as a pre- and post-treatment GID questionnaire, blood draw, and stool sample. Participants consumed more total and saturated fat, and less fiber and whole grains compared to the recommended intake. A significant reduction in IgG2 was observed in the GS group (p=0.008) as well as a significant reduction in self-reported bloating (p=0.038) with no change observed to cytokines or SCFAs (p&gt;0.05). GS was well tolerated and perceived to be beneficial; however, further research is needed to identify the specific population of GID patients who could most benefit from GS supplementation.","abstract_has_math":false,"creators":["Webb, Kaitlyn"],"institution":"East Tennessee State University","degree_name":"MS (Master of Science)","degree_level":"Thesis - unrestricted","degree_discipline":"Clinical Nutrition","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2019,"date_issued":"2019-05-01T07:00:00Z","date_published":"2019-05-01T07:00:00Z","updated_at":"2026-11-19T07:55:54Z","subjects":["gastrointestinal upset","short chain fatty acids","probiotic","prebiotic","GlutenShield","Dietetics and Clinical Nutrition"],"languages":["eng"],"rights":["Copyright by the authors."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dc.etsu.edu/etd/3562","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dc.etsu.edu/etd/3562","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":"https://dc.etsu.edu/context/etd/article/5023/viewcontent/WebbK041819f.pdf","download_label":"Download PDF","download_source":"dc:identifier","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dc.etsu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adc.etsu.edu%3Aetd-5023","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Webb, Kaitlyn"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-03-29T07:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2019-05-01T07:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["East Tennessee State University"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Clinical Nutrition"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis - unrestricted"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS (Master of Science)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["East Tennessee State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["gastrointestinal upset","short chain fatty acids","probiotic","prebiotic","GlutenShield","Dietetics and Clinical Nutrition"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright by the authors."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dc.etsu.edu/context/etd/article/5023/viewcontent/WebbK041819f.pdf","https://dc.etsu.edu/etd/3562"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Current practices support the use of probiotic and prebiotic supplementation to improve chronic gastrointestinal distress (GID). The aim of this study was to determine the tolerance and benefits of GlutenShield (GS), a prebiotic, probiotic, and enzyme supplement, on adults with GID. Subjects (n=20) took either GS or the placebo for 30 days and completed a pre-treatment FFQ as well as a pre- and post-treatment GID questionnaire, blood draw, and stool sample. Participants consumed more total and saturated fat, and less fiber and whole grains compared to the recommended intake. A significant reduction in IgG2 was observed in the GS group (p=0.008) as well as a significant reduction in self-reported bloating (p=0.038) with no change observed to cytokines or SCFAs (p>0.05). GS was well tolerated and perceived to be beneficial; however, further research is needed to identify the specific population of GID patients who could most benefit from GS supplementation."]},{"key":"dc:title","label":"Title","values":["Effect of Prebiotic, Probiotic, and Enzyme Supplementation on Gut Fermentation, Markers of Inflammation and Immune Response in Individuals with GI Symptoms"]}]}],"canonical_facts":{"dc:creator":["Webb, Kaitlyn"],"dc:date.available":["2019-03-29T07:00:00Z"],"dc:date.issued":["2019-05-01T07:00:00Z"],"dc:description.abstract":["Current practices support the use of probiotic and prebiotic supplementation to improve chronic gastrointestinal distress (GID). The aim of this study was to determine the tolerance and benefits of GlutenShield (GS), a prebiotic, probiotic, and enzyme supplement, on adults with GID. Subjects (n=20) took either GS or the placebo for 30 days and completed a pre-treatment FFQ as well as a pre- and post-treatment GID questionnaire, blood draw, and stool sample. Participants consumed more total and saturated fat, and less fiber and whole grains compared to the recommended intake. A significant reduction in IgG2 was observed in the GS group (p=0.008) as well as a significant reduction in self-reported bloating (p=0.038) with no change observed to cytokines or SCFAs (p>0.05). GS was well tolerated and perceived to be beneficial; however, further research is needed to identify the specific population of GID patients who could most benefit from GS supplementation."],"dc:identifier":["https://dc.etsu.edu/context/etd/article/5023/viewcontent/WebbK041819f.pdf","https://dc.etsu.edu/etd/3562"],"dc:language":["eng"],"dc:publisher":["East Tennessee State University"],"dc:rights":["Copyright by the authors."],"dc:subject":["gastrointestinal upset","short chain fatty acids","probiotic","prebiotic","GlutenShield","Dietetics and Clinical Nutrition"],"dc:title":["Effect of Prebiotic, Probiotic, and Enzyme Supplementation on Gut Fermentation, Markers of Inflammation and Immune Response in Individuals with GI Symptoms"],"thesis:degree_discipline":["Clinical Nutrition"],"thesis:degree_level":["Thesis - unrestricted"],"thesis:degree_name":["MS (Master of Science)"],"thesis:institution_name":["East Tennessee State University"]},"updated_at":"2026-11-19T07:55:54Z"}